RPS26P41

Across TCGA pan-cancer cohorts, RPS26P41 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RPS26P41 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher RPS26P41 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPS26P41 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LUAD show a favorable association.

UVM, THCA, and LIHC are the cancer types where RPS26P41 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Tertile	III,IV	0.277	0.668	.001	53	view →
THCA	DFS	Quartile	II,III,IV	0.425	0.821	.002	39	view →
LIHC	DFS	Tertile	All	0.366	0.567	<.001	36	view →
HNSC	OS	Quartile	IV	0.493	0.322	.013	30	view →
THYM	OS	Quartile	II,III,IV	0.858	0.981	.007	30	view →
KIRC	DFS	Quartile	II,III,IV	0.395	0.572	.007	22	view →
CHOL	OS	Median	All	0.275	0.732	<.001	22	view →
OV	OS	Quartile	IV	0.510	0.833	.013	12	view →
LUAD	OS	Quartile	All	0.600	0.399	.005	11	view →
SARC	OS	Tertile	All	0.900	0.789	.019	11	view →
PAAD	OS	Quartile	II,III,IV	0.383	0.611	.013	9	view →
UCS	OS	Tertile	III,IV	0.631	0.240	.046	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RPS26P41–UVM (DFS)

Open the UVM breakdown →